Searchable abstracts of presentations at key conferences in endocrinology

ea0028p32 | Clinical biochemistry | SFEBES2012

Vitamin D deficiency is associated with worsened biochemical features and poorer diagnostic accuracy in patients with primary hyperparathyroidism

Modi Manish , Jayasena Channa , Palazzo Fausto , Donaldson Mandy , Meeran Karim , Dhillo Waljit

Background: Vitamin D deficiency is a common feature of primary hyperparathyroidism (PHP). However, replacement of vitamin D is not routinely performed in clinical practice, due to concerns about its safety. Furthermore, it is not clear whether vitamin D deficiency worsens the biochemical derangements observed in patients with PHP.Aim: To determine the relationship between 25(OH) vitamin D status and biochemical markers in patients with PHP.<p class=...

ea0025p253 | Pituitary | SFEBES2011

Associations of overall GH and IGF1 exposure with ischaemic heart disease and cardiomyopathy in patients with treated acromegaly

Clarke Holly , Jayasena Channa , Comninos Alexander , Donaldson Mandy , Meeran Karim , Dhillo Waljit

Background: Patients with acromegaly require lifetime monitoring due to the excess mortality and morbidity associated with untreated disease, and the propensity for disease relapse following treatment. There is controversy whether GH or insulin-like growth factor 1 (IGF1), better predicts the onset of cardiovascular complications such as cardiomyopathy and ischaemic heart disease (IHD) in acromegalic patients.Aim: To examine associations of overall GH an...

ea0025p254 | Pituitary | SFEBES2011

Overall GH exposure is raised in acromegalic patients with type 2 diabetes and impaired glucose tolerance, when compared with euglycaemic acromegalic patients

Clarke Holly , Jayasena Channa , Comninos Alexander , Donaldson Mandy , Meeran Karim , Dhillo Waljit

Background: A cardinal feature of acromegaly is insulin resistance. Patients with acromegaly are therefore predisposed to developing impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM). It is therefore imperative to develop better biomarkers predicting the onset of IGT and T2DM in treated acromegalic patients. There is controversy whether GH or insulin-like growth factor 1 (IGF1) better predict the onset of IGT or T2DM in treated acromegalic patients. However ...

ea0077p110 | Reproductive Endocrinology | SFEBES2021

Clinical characteristics associated with testosterone prescribing in men in primary care

Sharma Aditi , Ul-Haq Zia , Sindi Emad , Al-Sharefi Ahmed , Kamalati Tahereh , Dhillo Waljit S. , Minhas Sukhbinder , Jayasena Channa N

Background: Testosterone replacement therapy (TRT) is widely used for the treatment of symptomatic hypogonadism in men. However, data on prescription behaviours of TRT are limited. The objective of this study was to investigate clinical characteristics associated with the likelihood of being prescribed TRT by general practitioners (GPs) in North West London (NWL).Methods: We carried out a retrospective cohort study using Discover database of GP-registere...

ea0065p377 | Reproductive Endocrinology and Biology | SFEBES2019

A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women

Dimakopoulou Anastasia , Jayasena Channa N , Alkaabi Fatima M , Liebers Curtis S , Handley Thomas , Franks Stephen , Dhillo Waljit S

Introduction: Over half of postmenopausal women suffer symptoms which can sometimes be non-responsive to hormone replacement therapy (HRT). Testosterone is implicated in regulating urogenital and sexual function in women. However, using testosterone therapy in postmenopausal women remains highly controversial, principally due to the lack of syndromic relationship between serum testosterone levels and onset of sexual dysfunction during menopause. Clinical practice is therefore ...

ea0038p352 | Reproduction | SFEBES2015

I.v. and s.c. infusions of kisspeptin-54 stimulate gonadotrophin release similarly in healthy women

Narayanaswamy Shakunthala , Jayasena Channa , Ng Noel , Ratnasabapathy Risheka , Papadopoulou Deborah , Prague Julia , Abbara Ali , Comninos Alexander , Bloom Stephen , Dhillo Waljit

Background: Kisspeptin stimulates hypothalamic GnRH secretion resulting in gonadotrophin release and has the potential as a future therapeutic for infertility. Previous studies have observed that kisspeptin increases LH and to a lesser degree FSH when administered to healthy women, which may limit its therapeutic potential. However, studies in women with hypothalamic amenorrhoea show that i.v. infusions of kisspeptin-54 stimulated both LH and FSH equally. Chronic s.c. infusion...

ea0035p617 | Female reproduction | ECE2014

Identification of elevated urine kisspeptin in pregnant women: a novel non-invasive biomarker of placental function?

Comninos Alexander , Jayasena Channa , Narayanaswamy Shakunthala , Abbara Ali , Nijher Gurjinder , Cheema Mansimran , Malik Zainab , Ghatei Mohammad , Bloom Stephen , Dhillo Waljit

Background: Kisspeptin is an RF amide peptide hormone critical for reproductive function. Kisspeptin is also abundantly expressed in the placenta, where it has an important physiological role in regulating placental invasion. Accordingly, plasma kisspeptin levels rise dramatically during normal pregnancy. Lower plasma levels of kisspeptin are associated with poor pregnancy outcomes such as recurrent miscarriage, intrauterine growth restriction and pre-eclampsia. Urinary measur...

ea0034yep1.2 | SfE Young Endocrinologists' prize lectures | SFEBES2014

Clinical effects of kisspeptin on reproductive hormone secretion, LH pulsatility and oocyte maturation

Jayasena Channa , Abbara Ali , Comninos Alexander , Nijher Gurjinder , Veldhuis Johannes , Carby Anna , Trew Geoffrey , Ghatei Mohammad , Bloom Stephen , Dhillo Waljit

A decade ago, genetic disruption of the kisspeptin signalling pathway was observed to cause hypogonadotrophic hypogonadism. Hypothalamic kisspeptin acts by stimulating secretion of endogenous GnRH. Our research has investigated the physiological effects of kisspeptin in women, with the overarching aim of determining if kisspeptin could be used to treat women with infertility.We initially observed that s.c. bolus injection of kisspeptin acutely stimulated...

ea0034p35 | Clinical biochemistry | SFEBES2014

Urinary kisspeptin as a novel marker of pregnancy

Comninos Alexander , Jayasena Channa , Narayanaswamy Shakunthala , Abbara Ali , Nijher Gurjinder , Cheema Mansimran , Malik Zainab , Ghatei Mohammad , Bloom Stephen , Dhillo Waljit

Background: Kisspeptin is an RF amide peptide hormone critical for reproductive function. Kisspeptin is also abundantly expressed in the placenta, where it has an important physiological role in regulating placental invasion. Accordingly, plasma kisspeptin levels rise dramatically during normal pregnancy. Lower plasma levels of kisspeptin are associated with poor pregnancy outcomes such as recurrent miscarriage, intrauterine growth restriction and pre-eclampsia. Urinary measur...

ea0081p697 | Reproductive and Developmental Endocrinology | ECE2022

Clinical/biochemical characteristics of functioning gonadotroph adenomas in women presenting with ovarian hyperstimulation

Papanikolaou Nikoleta , Coulden Amy , Parker Nina , Lee Sit , Kelly Chris , Anderson Richard , Rees Aled , Cox Jeremy , Dhillo Waljit , Meeran Karim , Al-Memar Maya , Karavitaki Niki , Jayasena Channa

Background: Functioning gonadotroph adenomas (FGA) are rare benign pituitary tumours. Several case reports suggest that FGA may present with features of ovarian hyperstimulation in women. However, a lack of aggregated clinical experience of FGA precludes the meaningful guidance of management in affected women.Methods: Case series of 7 women presenting at different UK sites with FGA induced ovarian hyperstimulation syndrome (OHSS).R...